Semaglutide TFA is a glucagon-like peptide-1 congener that induces weight loss, lowers blood glucose levels, and reduces cardiovascular risk in diabetic patients.Semaglutide TFA induces mild-to-moderate and transient gastrointestinal disturbances, and may be used in the study of type 2 diabetes and obesity.
Molecular Weight:
4225.6482
Purity:
99.69%
Formula:
C189H290F3N45O61
Target:
Glucagon Receptor
T12878
T12878
* VAT and and shipping costs not included. Errors and price changes excepted
